| |
| |
|
| Insider
Information: |
Bennett C Frank |
| Relationship: |
Officer Level 14 |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
79,462 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,161,793 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
79,462 |
|
|
| Total
Value |
$3,161,793 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
7
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -66.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
Officer Level 14 |
2024-02-29 |
79,462 |
2003-07-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
191 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 7 of 8
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-12-15 |
4 |
AS |
$56.00 |
$224,000 |
D/D |
(4,000) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-12-16 |
4 |
AS |
$58.85 |
$230,045 |
D/D |
(3,909) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-05-01 |
4 |
OE |
$6.81 |
$230,410 |
D/D |
29,945 |
8,255 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2016-11-09 |
4 |
OE |
$11.27 |
$257,012 |
D/D |
22,805 |
28,608 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-01-15 |
4 |
D |
$62.06 |
$258,294 |
D/D |
(4,162) |
32,195 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-01-18 |
4 |
S |
$38.89 |
$271,356 |
D/D |
(6,978) |
67,855 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Senior Vice President |
• – – |
2008-08-11 |
4 |
AS |
$18.03 |
$274,178 |
D/D |
(15,000) |
537 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2017-03-03 |
4 |
AS |
$55.00 |
$275,000 |
D/D |
(5,000) |
14,788 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-06 |
4 |
AS |
$56.00 |
$280,000 |
D/D |
(5,000) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-02 |
4 |
OE |
$39.87 |
$281,203 |
D/D |
7,053 |
39,529 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-09 |
4 |
AS |
$30.23 |
$302,250 |
D/D |
(10,000) |
2,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-20 |
4 |
OE |
$47.34 |
$307,710 |
D/D |
6,500 |
72,254 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-04 |
4 |
OE |
$39.87 |
$316,847 |
D/D |
7,947 |
40,423 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-11-10 |
4 |
AS |
$64.00 |
$320,000 |
D/D |
(5,000) |
7,316 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2023-12-20 |
4 |
S |
$49.64 |
$322,643 |
D/D |
(6,500) |
65,754 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-04-30 |
4 |
OE |
$11.12 |
$333,600 |
D/D |
30,000 |
32,110 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2021-01-15 |
4 |
D |
$61.28 |
$336,305 |
D/D |
(5,488) |
42,508 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
EVP, Chief Scientific Officer |
• – – |
2024-01-17 |
4 |
S |
$50.42 |
$340,063 |
D/D |
(6,745) |
77,323 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-09-19 |
4 |
AS |
$35.02 |
$350,200 |
D/D |
(10,000) |
2,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-02 |
4 |
AS |
$51.32 |
$361,960 |
D/D |
(7,053) |
32,476 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2013-12-05 |
4 |
AS |
$39.90 |
$399,182 |
D/D |
(10,000) |
2,866 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Scientific Officer |
• – – |
2020-12-04 |
4 |
AS |
$51.04 |
$405,615 |
D/D |
(7,947) |
32,476 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2014-06-23 |
4 |
AS |
$36.54 |
$411,910 |
D/D |
(11,200) |
4,336 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2015-03-23 |
4 |
AS |
$69.80 |
$420,020 |
D/D |
(6,000) |
7,229 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Research |
• – – |
2019-02-01 |
4 |
AS |
$58.29 |
$525,368 |
D/D |
(9,013) |
24,528 |
0 |
- |
|
191 Records found
|
|
Page 7 of 8 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
